Monographs: Dosage forms: Specific monographs: Chloroquine sulfate oral solution (Chloroquini sulfatis solutio peroralum)

Category. Antimalarial.

Storage. Chloroquine sulfate oral solution should be kept in a well-closed container, protected from light.

Labelling. The designation of the container of Chloroquine sulfate oral solution should state that the active ingredient is in the sulfate form and the quantity should be indicated in terms of the equivalent amount of chloroquine.

Additional information. Strength in the current WHO Model list of essential medicines: 50 mg of chloroquine per 5 mL (10 mg per mL). Strength in the current WHO Model list of essential medicines for children: 50 mg of chloroquine per 5 mL (10 mg per mL).

50 mg of chloroquine is equivalent to approximately 68 mg of chloroquine sulfate (H2O).

Requirements

Complies with the monograph for Liquids for Oral Use.

Definition. Chloroquine sulfate oral solution is a solution of Chloroquine sulfate in a suitable vehicle which may be flavoured. It contains not less than 90.0% and not more than 110.0% of the amount of chloroquine (C18H26ClN3) stated on the label.

Identity tests

A. Carry out test A.1 or, where UV detection is not available, test A.2.

A.1 Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R6 as the coating substance and a mixture of 5 volumes of chloroform R, 4 volumes of cyclohexane R and 1 volume of diethylamine R as the mobile phase. Apply separately to the plate 2 μL of each of the following two solutions. For solution (A) dilute a quantity of the oral solution containing the equivalent of 50 mg of chloroquine with 50 mL of water and add 4 mL of sodium hydroxide (~40 g/L) TS. Transfer to a separating funnel and extract with two 5 mL quantities of dichloromethane R. Use the combined dichloromethane extracts. For solution (B) use 6.8 mg chloroquine sulfate RS per mL of water R. After removing the plate from the chromatographic chamber allow it to dry exhaustively in air or a current of cool air and examine the chromatogram in ultraviolet light (254 nm).

The principal spot obtained with solution A corresponds in position, appearance and intensity to that obtained with solution B.

A.2 Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using the conditions described above under test A.1 but using silica gel R5 as the coating substance. Dip the plate in modified Dragendorff reagent TS. Examine the chromatogram in daylight.

The principal spot obtained with solution A corresponds in position, appearance and intensity to that obtained with solution B.

B. The absorption spectrum (1.6) of a solution prepared by diluting a quantity of the oral solution containing the equivalent of 50 mg of chloroquine to 100 mL with water R and diluting 2 mL of the resulting solution to 100 mL with water R, when observed between 240 nm and 360 nm, exhibits maxima at about 257 nm, 329 nm and 343 nm.

C. To a quantity of the oral solution containing the equivalent of 50 mg of chloroquine add 10 mL of water and 1 mL of hydrochloric acid (~70 g/L) TS and filter if necessary. To the filtrate add 1 mL of barium chloride (50 g/L) TS; a white precipitate is produced.

pH value (1.13). pH of the oral solution: 4.0–6.5.

Related substances

Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R6 as the coating substance and a mixture of 5 volumes of chloroform R, 4 volumes of cyclohexane R and 1 volume of diethylamine R as the mobile phase. Apply separately to the plate 2 μL of each of the following three solutions. For solution (1) dilute a quantity of the oral solution containing the equivalent of 0.20 g of chloroquine with 50 mL of water R and add 4 mL of sodium hydroxide (~40 g/L) TS. Transfer to a separating funnel and extract with two 5 mL quantities dichloromethane R. Use the combined dichloromethane extracts. For solution (2) dilute 2 mL of solution (1) to 200 mL with dichloromethane R. For solution (3) dilute 5 mL of solution (2) to 10 mL with dichloromethane R. After removing the plate from the chromatographic chamber allow it to dry exhaustively in air or a current of cool air and examine the chromatogram in ultraviolet light (254 nm).

Any spot in the chromatogram obtained with solution (1), other than the principal spot, is not more intense than that in the chromatogram obtained with solution (2) (1.0%), and no more than one such spot is more intense than that obtained with solution (3) (0.5%).

Assay

Transfer a quantity of the oral solution containing the equivalent of about 0.100 g of chloroquine, accurately weighed, to a separating funnel. Add 10 mL of sodium hydroxide (~40 g/L) TS and extract with four 25 mL quantities of dich loromethane R. Dry the combined extracts over 2 g anhydrous sodium sulfate R, filter, wash the residue with 25 mL of dichloromethane R, combine the dichloromethane extracts and evaporate to about 10 mL, add 40 mL of glacial acetic acid R1 and titrate with perchloric acid (0.1 mol/L) VS, determine the end-point potentiometrically as described under 2.6 Non aqueous titration, Method A. Each mL of perchloric acid (0.1 mol/L) VS is equivalent to 15.99 mg of C18H26ClN3. Determine the weight per mL (1.3.1) of the oral solution and calculate the content of chloroquine (C18H26ClN3) weight in volume in the oral solution.

to previous sectionto next section